Lataa...
Renal outcomes of treatment with telmisartan in patients with stage 3–4 chronic kidney disease: A prospective, randomized, controlled trial (JINNAGA)
OBJECTIVES: Although angiotensin II receptor blockers are effective for patients with chronic kidney disease, dose-dependent renoprotective effects of angiotensin II receptor blockers in patients with moderate to severe chronic kidney disease with non-nephrotic proteinuria are not known. Our aim was...
Tallennettuna:
| Julkaisussa: | SAGE Open Med |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7686635/ https://ncbi.nlm.nih.gov/pubmed/33282300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050312120973502 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|